v3.25.1
PROLEUKIN ACQUISITION - Additional information (Details)
$ in Thousands, £ in Millions
3 Months Ended
May 18, 2023
USD ($)
May 18, 2023
GBP (£)
Mar. 31, 2025
USD ($)
Mar. 31, 2024
USD ($)
Mar. 31, 2024
GBP (£)
PROLEUKIN ACQUISITION          
Finite-lived intangible assets       $ 17,500 £ 13.9
Accrued offering costs in accounts payable and accrued expenses     $ 0 552  
PROLEUKIN          
PROLEUKIN ACQUISITION          
Total cost of acquisition $ 222,672   222,700    
Cash payment 207,200 £ 166.9 210,200    
Direct transaction costs incurred     $ 12,500    
Contingent cash payments, milestone payment $ 52,600 £ 41.7      
Deferred consideration term 12 years 12 years      
Contingent consideration paid for acquisition       $ 52,600 £ 41.7
PROLEUKIN | Developed technology          
PROLEUKIN ACQUISITION          
Expected useful life of intangible assets 15 years 15 years      
Weighted average amortization period     14 years 9 months 18 days    
PROLEUKIN | Assembled workforce          
PROLEUKIN ACQUISITION          
Weighted average amortization period     14 years 9 months 18 days    
PROLEUKIN | Assembled workforce | Selling, general and administrative          
PROLEUKIN ACQUISITION          
Expected useful life of intangible assets 3 years 3 years